Albert Seymour - 06 Sep 2022 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)

Role
President and Chief Executive Officer Exhibit 24 - Power of Attorney, Director
Signature
/s/ W. Bradford Smith, Attorney-in-Fact for Albert Seymour
Issuer symbol
QTTB
Transactions as of
06 Sep 2022
Net transactions value
$0
Form type
4
Filing time
08 Sep 2022, 16:05:16 UTC
Previous filing
21 Apr 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIXX Employee Stock Option (Right to Buy) Award $0 +23,000 $0.000000 23,000 06 Sep 2022 Common Stock 23,000 $2.18 Direct F1
transaction FIXX Restricted Stock Units Award $0 +14,000 $0.000000 14,000 06 Sep 2022 Common Stock 14,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following September 6, 2022.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
F3 The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of September 6, 2022 so that such RSUs will become fully vested on September 6, 2025.

Remarks:

President and Chief Executive Officer Exhibit 24 - Power of Attorney